282 related articles for article (PubMed ID: 17277959)
1. The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases.
Sitaru C; Mihai S; Zillikens D
Arch Dermatol Res; 2007 Apr; 299(1):1-8. PubMed ID: 17277959
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of blister induction by autoantibodies.
Sitaru C; Zillikens D
Exp Dermatol; 2005 Dec; 14(12):861-75. PubMed ID: 16274453
[TBL] [Abstract][Full Text] [Related]
3. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
Dainichi T; Chow Z; Kabashima K
J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
[TBL] [Abstract][Full Text] [Related]
4. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
Brooks WS; Lee YY; Abell E; Deng JS
J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
[TBL] [Abstract][Full Text] [Related]
5. [Molecular advances in pathogenesis of autoimmune blistering skin diseases].
Mouquet H; Gilbert D; Musette P; Tron F; Joly P
Ann Dermatol Venereol; 2005 Mar; 132(3):231-42. PubMed ID: 15924045
[TBL] [Abstract][Full Text] [Related]
6. Complement and cutaneous autoimmune blistering diseases.
Lessey E; Li N; Diaz L; Liu Z
Immunol Res; 2008; 41(3):223-32. PubMed ID: 18641925
[TBL] [Abstract][Full Text] [Related]
7. Pemphigus foliaceus.
Dasher D; Rubenstein D; Diaz LA
Curr Dir Autoimmun; 2008; 10():182-94. PubMed ID: 18460886
[TBL] [Abstract][Full Text] [Related]
8. Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering.
Yoshida K; Ishii K; Shimizu A; Yokouchi M; Amagai M; Shiraishi K; Shirakata Y; Stanley JR; Ishiko A
J Dermatol Sci; 2017 Mar; 85(3):197-207. PubMed ID: 28024684
[TBL] [Abstract][Full Text] [Related]
9. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.
Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H
J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071
[TBL] [Abstract][Full Text] [Related]
10. Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid.
Toosi S; Bystryn JC
Med Hypotheses; 2010 Apr; 74(4):727-8. PubMed ID: 19945799
[TBL] [Abstract][Full Text] [Related]
11. Immunopathologic mechanisms in pemphigus and bullous pemphigoid.
Jordon RE; Kawana S; Fritz KA
J Invest Dermatol; 1985 Jul; 85(1 Suppl):72s-78s. PubMed ID: 3891883
[TBL] [Abstract][Full Text] [Related]
12. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.
Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ
Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
[TBL] [Abstract][Full Text] [Related]
14. IgG4 autoantibodies induce dermal-epidermal separation.
Mihai S; Chiriac MT; Herrero-González JE; Goodall M; Jefferis R; Savage CO; Zillikens D; Sitaru C
J Cell Mol Med; 2007; 11(5):1117-28. PubMed ID: 17979887
[TBL] [Abstract][Full Text] [Related]
15. What's new in blistering disorders?
Chaudhari P; Marinkovich MP
Curr Allergy Asthma Rep; 2007 Jul; 7(4):255-63. PubMed ID: 17547846
[TBL] [Abstract][Full Text] [Related]
16. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus.
Vu TN; Lee TX; Ndoye A; Shultz LD; Pittelkow MR; Dahl MV; Lynch PJ; Grando SA
Arch Dermatol; 1998 Aug; 134(8):971-80. PubMed ID: 9722727
[TBL] [Abstract][Full Text] [Related]
17. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
18. A case of autoimmune bullous dermatosis with features of pemphigus vulgaris and bullous pemphigoid.
Kore-eda S; Horiguchi Y; Ohtoshi E; Tanaka T; Fujii K; Okamoto H; Ikai K; Imamura S
Am J Dermatopathol; 1995 Oct; 17(5):511-6. PubMed ID: 8599459
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune bullous dermatoses.
Cunha PR; Barraviera SR
An Bras Dermatol; 2009; 84(2):111-24. PubMed ID: 19503978
[TBL] [Abstract][Full Text] [Related]
20. Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris.
Lo AS; Mao X; Mukherjee EM; Ellebrecht CT; Yu X; Posner MR; Payne AS; Cavacini LA
PLoS One; 2016; 11(6):e0156800. PubMed ID: 27304671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
